Moreover, compared with Tg-Neu;EZH2WT and Tg-Neu mice, Tg-Neu;EZH2T416D mice developed multiple mammary tumors with much shorter latency and survival (Fig. 1d, purple line) although the transgene expression levels were similar (Supplementary Fig. 1e). This evidence concerns the gene ERBB2 and breast cancer.